eanCast: Weekly Neurology

ean.org
undefined
Sep 29, 2024 • 22min

Ep. 115: Can we prevent dementia?

EAN moderator: Youssuf Saleh (Oxford, United Kingdom) Guest: Sebastiaan Engelborghs (Brussel, Belgium) In this episode Youssuf Saleh and Sebastiaan Engelborghs discuss dementia prevention, with particular reference to the recently published lancet commis EAN moderator: Youssuf Saleh (Oxford, United Kingdom)Guest: Sebastiaan Engelborghs (Brussel, Belgium)In this episode Youssuf Saleh and Sebastiaan Engelborghs discuss dementia prevention, with particular reference to the recently published lancet commission report on dementia prevention, intervention and care. Key areas of discussion include what those risks are, how they can be mitigated and what adaptations the field of neurology and public health need to minimise the burden of dementia in aging populations.
undefined
Sep 22, 2024 • 29min

Ep. 114: Neurological Prognosis and Treatment after Cardiac Arrest

EAN moderator: Marian Galovic (Zurich, Switzerland) Guest: Michel van Putten (Enschede, The Netherlands) In this episode, Marian Galovic talks with Prof. Michel van Putten about the effects of cardiac arrest on the brain. They highlight the role of EEG EAN moderator: Marian Galovic (Zurich, Switzerland)Guest: Michel van Putten (Enschede, The Netherlands) In this episode, Marian Galovic talks with Prof. Michel van Putten about the effects of cardiac arrest on the brain. They highlight the role of EEG in assessing long-term prognosis following cardiac arrest and discuss the treatment of rhythmic or periodic EEG patterns.
undefined
Sep 15, 2024 • 20min

Ep. 113: New EAN Guideline on the Management of Amyotrophic Lateral Sclerosis

Moderator: Federica Agosta (Milan, Italy) Guest: Philip van Damme (Leuven, Belgium) In this week’s episodes Federica Agosta hosts Philip van Damme as they discuss the new EAN Guideline on the Management of Amyotrophic Lateral Sclerosis. Find more information here.
undefined
Sep 8, 2024 • 27min

Ep. 112: Brain Circuits: Principles and Translational Applications

EAN moderator: Youssuf Saleh (Oxford, United Kingdom) Guest: Thanh Doan (Trondheim, Norway) For this episodes Youssuf Saleh is joined by Thanh Doan as they discuss the role of brain circuits in neuroscience and how they can be used to advance both our un EAN moderator: Youssuf Saleh (Oxford, United Kingdom)Guest: Thanh Doan (Trondheim, Norway)For this episodes Youssuf Saleh is joined by Thanh Doan as they discuss the role of brain circuits in neuroscience and how they can be used to advance both our understanding of disease and lay foundations for circuit-based treatments including neuromodulation.
undefined
Sep 1, 2024 • 33min

Ep. 111: ECTRIMS-EAN Vaccination Consensus Statement

EAN Moderator: Melinda Magyari (Copenhagen, Denmark) Special Moderator: Brett Drummond (Melbourne, Australia) Guest: Susana Otero (Barcelona, Spain) In this episode eanCast: Weekly Neurology is joined by The ECTRIMS Podcast. Hosts Melinda Magyari and Br EAN Moderator: Melinda Magyari (Copenhagen, Denmark)Special Moderator: Brett Drummond (Melbourne, Australia)Guest: Susana Otero (Barcelona, Spain)In this episode eanCast: Weekly Neurology is joined by The ECTRIMS Podcast. Hosts Melinda Magyari and Brett Drummond talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero. Find the full article here.
undefined
Aug 25, 2024 • 22min

Ep. 110: Family Planning Management in Multiple Sclerosis

Moderator: Melinda Magyari (Copenhagen, Denmark) Guest: Celia Oreja-Guevara (Madrid, Spain) In this last August episode Melinda Magyari hosts Celia Oreja-Guevara as they explore the impact of MS on women's fertility, the shift in advice regarding pregnan Moderator: Melinda Magyari (Copenhagen, Denmark)Guest: Celia Oreja-Guevara (Madrid, Spain)In this last August episode Melinda Magyari hosts Celia Oreja-Guevara as they explore the impact of MS on women's fertility, the shift in advice regarding pregnancy, and how pregnancy affects MS activity. They also discuss the importance of consulting a neurologist, considerations for artificial reproduction techniques, and recommendations for disease-modifying therapies, including treating relapses during pregnancy and breastfeeding.
undefined
Aug 18, 2024 • 24min

Ep. 109: The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments

Moderator: Melinda Magyari (Copenhagen, Denmark) Guest: Thomas Berger (Vienna, Austria) Melinda Magyari and her guest Thomas Berger talk about how aging affects MS progression and management, focusing on immunosenescence's impact on the immune response Moderator: Melinda Magyari (Copenhagen, Denmark)Guest: Thomas Berger (Vienna, Austria)Melinda Magyari and her guest Thomas Berger talk about how aging affects MS progression and management, focusing on immunosenescence's impact on the immune response and DMT effectiveness. They cover the rise of comorbidities in older MS patients, the challenges of using DMTs over age 55, the lack of clinical trials for this age group, and share lifestyle tips to improve quality of life and health outcomes.
undefined
Aug 11, 2024 • 27min

Ep. 108: Central Vein Sign and Chronic Active Lesions: Relevance for Diagnosis and Prognosis in Multiple Sclerosis

Moderator: Melinda Magyari (Copenhagen, Denmark) Guest: Nikolaos Grigoriadis (Thessaloniki, Greece) Melinda Magyari hosts Paolo Preziosa as they delve into the significance of central vein sign and chronic active lesions in multiple sclerosis diagnosis a Moderator: Melinda Magyari (Copenhagen, Denmark)Guest: Nikolaos Grigoriadis (Thessaloniki, Greece)Melinda Magyari hosts Paolo Preziosa as they delve into the significance of central vein sign and chronic active lesions in multiple sclerosis diagnosis and prognosis. They explore how these MRI biomarkers enhance diagnostic accuracy and predict disease progression, emphasizing their potential clinical relevance and the need for further research to optimize MS treatment strategies.
undefined
Aug 4, 2024 • 26min

Ep. 107: Is EBV the Key Player in Multiple Sclerosis Pathogenesis?

Moderator: Melinda Magyari (Copenhagen, Denmark) Guest: Nikolaos Grigoriadis (Thessaloniki, Greece) Follow Melinda Magyari and her guest Nikolaos Grigoriadis in the first MS episode of this month as they explore the Epstein-Barr Virus and its potential Moderator: Melinda Magyari (Copenhagen, Denmark)Guest: Nikolaos Grigoriadis (Thessaloniki, Greece)Follow Melinda Magyari and her guest Nikolaos Grigoriadis in the first MS episode of this month as they explore the Epstein-Barr Virus and its potential link to multiple sclerosis. They discuss how EBV might trigger or worsen MS, the challenges in confirming this connection, and implications for treatment and prevention. Other MS risk factors, such as genetics, environment, vitamin D levels, and lifestyle, are also covered.
undefined
Jul 21, 2024 • 29min

Ep. 106: Phenoconversion in Pure Autonomic Failure

Moderator: Anne Pavy-Le Traon (Toulouse, France) Guests: Giovanna Calandra-Buonaura (Bologna, Italy) and Valeria Iodice (London, United Kingdom) In this week’s podcast episode Anne Pavy-Le Traon hosts two guests, Giovanna Calandra Buonaura and Valeria I Moderator: Anne Pavy-Le Traon (Toulouse, France)Guests: Giovanna Calandra-Buonaura (Bologna, Italy) and Valeria Iodice (London, United Kingdom) In this week’s podcast episode Anne Pavy-Le Traon hosts two guests, Giovanna Calandra Buonaura and Valeria Iodice, as they discuss a hot topic related to Phenoconversion in Pure Autonomic Failure (PAF). They highlight the natural history of PAF and the importance of recognising this disease as a possible prodromal/ premotor phase of other alpha synucleinopathies. They discuss novel clinical and multimodal biomarkers in early diagnosis of these disorders.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app